Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

DME competitive bidding

This article was originally published in The Gray Sheet

Executive Summary

Advisory and oversight committee for durable medical equipment competitive bidding implementation should review CMS' draft plan, including a list of proposed products to be bid on, before the program becomes effective, AdvaMed urges CMS in a recent letter. Manufacturers also should have more than one representative on the committee to "ensure consideration of the unique issues relating to different categories/types of products" covered, the group says. Under the Medicare Modernization Act, competitive bidding will become effective for the 10 largest metropolitan statistical areas in 2007, growing to 80 in 2009 (1"The Gray Sheet" Dec. 1, 2003, p. 3)...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT020114

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel